SCHEMBL5337489

SCHEMBL5337489

CCCc1ccc(S(=O)(=O)Nc2ccc3nc(C)cnc3c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.55
MAPT P10636 1/20 0.55
NR1I2 O75469 1/20 0.53
KIT P10721 2/20 0.51
FFAR4 Q5NUL3 2/20 0.50
CDC7 O00311 1/20 0.50
EEF2K O00418 1/20 0.50
PLK4 O00444 1/20 0.50
AURKA O14965 1/20 0.50
DYRK3 O43781 1/20 0.50
RPS6KA5 O75582 1/20 0.50
PRKD3 O94806 1/20 0.50
MAP4K4 O95819 1/20 0.50
PIM1 P11309 1/20 0.50
PHKG2 P15735 1/20 0.50
CDK2 P24941 1/20 0.50
AKT1 P31749 1/20 0.50
AKT2 P31751 1/20 0.50
MAPK8 P45983 1/20 0.50
MAPKAPK2 P49137 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5335098 0.85 CDC7 (0.68) ATMMAPTNR1I2KITFFAR4
SCHEMBL5389593 0.84 NR1I2 (0.58) ATMMAPTNR1I2KITFFAR4
SCHEMBL5335572 0.83 MAPT (0.57) ATMMAPTNR1I2KITFFAR4
SCHEMBL5344513 0.79 ATM (0.52) ATMMAPTNR1I2KITFFAR4
SCHEMBL5340962 0.78 ALDH1A1 (0.72) ATMMAPTNR1I2KITFFAR4
SCHEMBL616006 0.77 PTPN2 (0.59) ATMMAPTNR1I2KITFFAR4
SCHEMBL618559 0.77 LMNA (0.74) ATMMAPTFFAR4POLBALDH1A1
SCHEMBL617843 0.77 MAPT (0.55) ATMMAPTNR1I2KITFFAR4
SCHEMBL10089745 0.77 LMNA (0.60) ATMMAPTNR1I2KITFFAR4
SCHEMBL617343 0.76 NR1I2 (0.58) ATMMAPTNR1I2POLBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 ATM 4236/4885MAPT 4512/4885NR1I2 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.